Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 27 studies | 26% ± 9% | |
fibroblast | 18 studies | 28% ± 11% | |
endothelial cell of lymphatic vessel | 15 studies | 26% ± 7% | |
smooth muscle cell | 14 studies | 24% ± 8% | |
pericyte | 14 studies | 27% ± 12% | |
type I pneumocyte | 10 studies | 27% ± 8% | |
capillary endothelial cell | 10 studies | 23% ± 7% | |
endothelial cell of artery | 9 studies | 22% ± 3% | |
vein endothelial cell | 9 studies | 25% ± 15% | |
myofibroblast cell | 6 studies | 22% ± 11% | |
basal cell | 5 studies | 18% ± 3% | |
endothelial cell of vascular tree | 5 studies | 24% ± 11% | |
connective tissue cell | 5 studies | 28% ± 13% | |
ionocyte | 3 studies | 36% ± 9% | |
glomerular endothelial cell | 3 studies | 38% ± 3% | |
epithelial cell | 3 studies | 27% ± 6% | |
astrocyte | 3 studies | 23% ± 8% |
Insufficient scRNA-seq data for expression of LAMB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 20287.61 | 1808 / 1809 | 100% | 200.41 | 471 / 472 |
kidney | 100% | 19487.19 | 89 / 89 | 99% | 171.85 | 893 / 901 |
prostate | 100% | 23829.43 | 244 / 245 | 99% | 139.84 | 499 / 502 |
breast | 100% | 25911.18 | 459 / 459 | 98% | 163.82 | 1100 / 1118 |
ovary | 100% | 38277.91 | 180 / 180 | 98% | 106.63 | 421 / 430 |
adrenal gland | 100% | 31721.84 | 258 / 258 | 97% | 131.72 | 223 / 230 |
thymus | 100% | 28554.36 | 653 / 653 | 96% | 133.76 | 583 / 605 |
lung | 100% | 23680.88 | 578 / 578 | 93% | 73.81 | 1078 / 1155 |
esophagus | 99% | 24504.68 | 1432 / 1445 | 93% | 72.33 | 171 / 183 |
stomach | 100% | 17315.62 | 359 / 359 | 90% | 70.88 | 257 / 286 |
bladder | 100% | 21777.81 | 21 / 21 | 87% | 64.61 | 440 / 504 |
pancreas | 88% | 6454.54 | 290 / 328 | 96% | 119.37 | 171 / 178 |
intestine | 99% | 20360.22 | 957 / 966 | 84% | 54.69 | 441 / 527 |
uterus | 100% | 31056.79 | 170 / 170 | 82% | 76.74 | 375 / 459 |
liver | 76% | 5676.15 | 171 / 226 | 93% | 77.39 | 379 / 406 |
brain | 27% | 1465.56 | 714 / 2642 | 99% | 98.33 | 700 / 705 |
adipose | 100% | 26636.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 38924.29 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 193.74 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 52.40 | 1 / 1 |
spleen | 100% | 13870.24 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 32983.70 | 857 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 10485.78 | 783 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 69% | 40.44 | 31 / 45 |
lymph node | 0% | 0 | 0 / 0 | 41% | 14.09 | 12 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007601 | Biological process | visual perception |
GO_0072249 | Biological process | metanephric podocyte development |
GO_0051149 | Biological process | positive regulation of muscle cell differentiation |
GO_2001046 | Biological process | positive regulation of integrin-mediated signaling pathway |
GO_0007155 | Biological process | cell adhesion |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0007528 | Biological process | neuromuscular junction development |
GO_0014044 | Biological process | Schwann cell development |
GO_0014002 | Biological process | astrocyte development |
GO_0072274 | Biological process | metanephric glomerular basement membrane development |
GO_0110011 | Biological process | regulation of basement membrane organization |
GO_0048677 | Biological process | axon extension involved in regeneration |
GO_0007411 | Biological process | axon guidance |
GO_0005576 | Cellular component | extracellular region |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0043260 | Cellular component | laminin-11 complex |
GO_0098637 | Cellular component | protein complex involved in cell-matrix adhesion |
GO_0043083 | Cellular component | synaptic cleft |
GO_0005604 | Cellular component | basement membrane |
GO_0005608 | Cellular component | laminin-3 complex |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0005198 | Molecular function | structural molecule activity |
GO_0005178 | Molecular function | integrin binding |
GO_0150043 | Molecular function | structural constituent of synapse-associated extracellular matrix |
GO_0005515 | Molecular function | protein binding |
Gene name | LAMB2 |
Protein name | Laminin subunit beta 2 Laminin subunit beta-2 (Laminin B1s chain) (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta) (S-LAM beta) |
Synonyms | LAMS |
Description | FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. |
Accessions | ENST00000494831.1 F5H520 ENST00000418109.5 ENST00000305544.9 P55268 |